UniProt ID | UBCP1_HUMAN | |
---|---|---|
UniProt AC | Q8WVY7 | |
Protein Name | Ubiquitin-like domain-containing CTD phosphatase 1 | |
Gene Name | UBLCP1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 318 | |
Subcellular Localization | Nucleus . Colocalizes with nuclear proteasomes. | |
Protein Description | Dephosphorylates 26S nuclear proteasomes, thereby decreasing their proteolytic activity. The dephosphorylation may prevent assembly of the core and regulatory particles (CP and RP) into mature 26S proteasome.. | |
Protein Sequence | MALPIIVKWGGQEYSVTTLSEDDTVLDLKQFLKTLTGVLPERQKLLGLKVKGKPAENDVKLGALKLKPNTKIMMMGTREESLEDVLGPPPDNDDVVNDFDIEDEVVEVENREENLLKISRRVKEYKVEILNPPREGKKLLVLDVDYTLFDHRSCAETGVELMRPYLHEFLTSAYEDYDIVIWSATNMKWIEAKMKELGVSTNANYKITFMLDSAAMITVHTPRRGLIDVKPLGVIWGKFSEFYSKKNTIMFDDIGRNFLMNPQNGLKIRPFMKAHLNRDKDKELLKLTQYLKEIAKLDDFLDLNHKYWERYLSKKQGQ | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MALPIIVKW ------CCCCEEEEE | 23.26 | 22223895 | |
29 | Ubiquitination | DDTVLDLKQFLKTLT CCCEEEHHHHHHHHH | 38.38 | 29967540 | |
49 | Acetylation | RQKLLGLKVKGKPAE HHHHHCCEECCCCCC | 39.85 | 25953088 | |
65 | Acetylation | DVKLGALKLKPNTKI CCEECEEECCCCCEE | 54.66 | 25953088 | |
65 | Ubiquitination | DVKLGALKLKPNTKI CCEECEEECCCCCEE | 54.66 | - | |
67 | Ubiquitination | KLGALKLKPNTKIMM EECEEECCCCCEEEE | 34.33 | 29967540 | |
71 | Acetylation | LKLKPNTKIMMMGTR EECCCCCEEEECCCC | 34.93 | 25953088 | |
71 | Ubiquitination | LKLKPNTKIMMMGTR EECCCCCEEEECCCC | 34.93 | 29967540 | |
81 | Phosphorylation | MMGTREESLEDVLGP ECCCCHHHHHHHHCC | 32.10 | 26657352 | |
117 | Acetylation | NREENLLKISRRVKE CHHHHHHHHHHHHHC | 41.63 | 19608861 | |
117 | Malonylation | NREENLLKISRRVKE CHHHHHHHHHHHHHC | 41.63 | 26320211 | |
117 | Ubiquitination | NREENLLKISRRVKE CHHHHHHHHHHHHHC | 41.63 | 32015554 | |
138 | Ubiquitination | NPPREGKKLLVLDVD CCCCCCCEEEEEECE | 58.89 | 33845483 | |
193 | Acetylation | NMKWIEAKMKELGVS CCHHHHHHHHHHCCC | 37.40 | 25953088 | |
193 | Ubiquitination | NMKWIEAKMKELGVS CCHHHHHHHHHHCCC | 37.40 | 23000965 | |
195 | Ubiquitination | KWIEAKMKELGVSTN HHHHHHHHHHCCCCC | 49.43 | 23000965 | |
200 | Phosphorylation | KMKELGVSTNANYKI HHHHHCCCCCCCCEE | 17.72 | 20068231 | |
201 | Phosphorylation | MKELGVSTNANYKIT HHHHCCCCCCCCEEE | 35.62 | 21406692 | |
205 | Phosphorylation | GVSTNANYKITFMLD CCCCCCCCEEEEEEC | 11.01 | 21406692 | |
213 | Phosphorylation | KITFMLDSAAMITVH EEEEEECCCEEEEEE | 17.61 | 24114839 | |
230 | Ubiquitination | RRGLIDVKPLGVIWG CCCCCCCEECEEEEE | 30.67 | 21906983 | |
240 | Phosphorylation | GVIWGKFSEFYSKKN EEEEEEHHHHHHCCC | 30.22 | 22817900 | |
243 | Phosphorylation | WGKFSEFYSKKNTIM EEEHHHHHHCCCEEE | 18.61 | 22817900 | |
244 | Phosphorylation | GKFSEFYSKKNTIMF EEHHHHHHCCCEEEE | 42.34 | 22817900 | |
245 | Ubiquitination | KFSEFYSKKNTIMFD EHHHHHHCCCEEEEC | 38.37 | 32015554 | |
245 | Succinylation | KFSEFYSKKNTIMFD EHHHHHHCCCEEEEC | 38.37 | 23954790 | |
245 | Acetylation | KFSEFYSKKNTIMFD EHHHHHHCCCEEEEC | 38.37 | 23749302 | |
246 | Ubiquitination | FSEFYSKKNTIMFDD HHHHHHCCCEEEECC | 54.07 | 30230243 | |
246 | 2-Hydroxyisobutyrylation | FSEFYSKKNTIMFDD HHHHHHCCCEEEECC | 54.07 | - | |
248 | Phosphorylation | EFYSKKNTIMFDDIG HHHHCCCEEEECCCC | 23.77 | - | |
267 | Ubiquitination | MNPQNGLKIRPFMKA CCCCCCCCCHHHHHH | 37.76 | 23000965 | |
273 | Ubiquitination | LKIRPFMKAHLNRDK CCCHHHHHHHHCCCC | 32.79 | 23000965 | |
280 | Ubiquitination | KAHLNRDKDKELLKL HHHHCCCCCHHHHHH | 68.42 | 23000965 | |
280 | Acetylation | KAHLNRDKDKELLKL HHHHCCCCCHHHHHH | 68.42 | 23749302 | |
282 | Ubiquitination | HLNRDKDKELLKLTQ HHCCCCCHHHHHHHH | 56.87 | 23000965 | |
282 | Acetylation | HLNRDKDKELLKLTQ HHCCCCCHHHHHHHH | 56.87 | 25953088 | |
286 | Ubiquitination | DKDKELLKLTQYLKE CCCHHHHHHHHHHHH | 63.21 | 23000965 | |
288 | Phosphorylation | DKELLKLTQYLKEIA CHHHHHHHHHHHHHH | 17.36 | 20068231 | |
292 | Ubiquitination | LKLTQYLKEIAKLDD HHHHHHHHHHHCCHH | 41.98 | 23000965 | |
296 | Ubiquitination | QYLKEIAKLDDFLDL HHHHHHHCCHHHHCC | 59.10 | 21906983 | |
306 | Ubiquitination | DFLDLNHKYWERYLS HHHCCCHHHHHHHHH | 51.49 | 32015554 | |
306 | Acetylation | DFLDLNHKYWERYLS HHHCCCHHHHHHHHH | 51.49 | 23954790 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of UBCP1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of UBCP1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of UBCP1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-117 AND LYS-306, AND MASSSPECTROMETRY. |